Liminatus Pharma
LIMN----
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: Liminatus Pharma(LIMN) the EBIT is -1.101 M (-316.7%);the EPS is -0.0312 (-66.79%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B316.66%
----
----
EPS
-0.031266.79%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf